Stay updated on FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.

Latest updates to the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedDifference0.9%
- Check13 days agoChange DetectedDifference1%
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference1%
- Check34 days agoChange DetectedThe webpage has been updated to include new drug information and a revised version number, while significant details about FT500 and its clinical trial criteria have been removed.SummaryDifference40%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference1%
- Check49 days agoChange DetectedThe page has updated its cancer-related content by adding information on Renal Cell Carcinoma and Pancreatic Cancer while removing references to Lymphosarcoma and Small Cell Lung Cancer. Additionally, the page has been revised from version 2.14.2 to 2.14.3.SummaryDifference1%
Stay in the know with updates to FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.